Michael Arrington’s recently announced decision to jump from journalist to investor (journovesting?) may have raised eyebrows in some circles (more from traditional media than new media, according to this interesting recent commentary), but he’s hardly the first reporter to leap into the arena. Especially...
Posted to
News
by
Health. Care.
on
Fri, Sep 9 2011
Filed under:
Filed under: google, byline=David Shaywitz, Business, Investing, New York Times, Morgan Stanley, Sequoia Capital, lazard, Tech, Millennium Technology Ventures, hedge fund, Fortune, Alsop Louie Partners, Media & Entertainment, Michael Moritz, WSJ, yahoo, TechCrunch, Alfred Winslow Jones
As promised, Scott Hensley with Fox News on what the buy out means. It discusses the investment portions as well as the expense and difficulty today in bringing new products to market. Lipitor, is due to come off patent and they need more in the pipeline and the birthplace factory for Lipitor...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Mon, Jan 26 2009
Filed under:
Filed under: Medically Related, Pharma/FDA News, drugs, healthcare, Pharma, Biotech, FDA, Science, Pharmaceuticals, Wyeth, Pfizer, Investing, Investments, Fox News, WSJ, Buyout, WSJ healthcare blog
Two featured posts this week. Court Blocks White House Push on Medicare Expenses This particular statement really bothers me, is CMS now going to take on the role of “doctor here? “The Bush administration argued that Medicare officials had the right to decide whether the expense incurred...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Thu, Nov 6 2008
Filed under:
Filed under: Medically Related, Insurance, Other Items of Interest, healthcare, medicare, health insurance, AARP, CMS, Medical Quack, Bush Administration, Risk Management, WSJ